Efficacy of a novel phosphodiesterase inhibitor, E6005, in patients with atopic dermatitis: An investigator-blinded, vehicle-controlled study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of a novel phosphodiesterase inhibitor, E6005, in patients with atopic dermatitis: An investigator-blinded, vehicle-controlled study
Authors
Keywords
-
Journal
JOURNAL OF DERMATOLOGICAL TREATMENT
Volume 27, Issue 5, Pages 467-472
Publisher
Informa UK Limited
Online
2016-04-15
DOI
10.3109/09546634.2016.1157257
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A putative antipruritic mechanism of the phosphodiesterase-4 inhibitor E6005 by attenuating capsaicin-induced depolarization of C-fibre nerves
- (2015) Hisashi Wakita et al. EXPERIMENTAL DERMATOLOGY
- Safety, tolerability and pharmacokinetics of a novel phosphodiesterase inhibitor, E6005 ointment, in healthy volunteers and in patients with atopic dermatitis
- (2015) Fuminori Ohba et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Is Adult Atopic Eczema More Common Than We Think? – A Population-based Study in Danish Adults
- (2014) G Vinding et al. ACTA DERMATO-VENEREOLOGICA
- Topical E6005, a novel phosphodiesterase 4 inhibitor, attenuates spontaneous itch-related responses in mice with chronic atopy-like dermatitis
- (2014) Tsugunobu Andoh et al. EXPERIMENTAL DERMATOLOGY
- Antipruritic mechanisms of topical E6005, a phosphodiesterase 4 inhibitor: Inhibition of responses to proteinase-activated receptor 2 stimulation mediated by increase in intracellular cyclic AMP
- (2014) Tsugunobu Andoh et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: Results of a randomized, vehicle-controlled, multicenter clinical trial
- (2014) Masutaka Furue et al. JOURNAL OF DERMATOLOGY
- Systemic therapy for atopic dermatitis
- (2013) D. Simon et al. ALLERGY
- Characterization of different courses of atopic dermatitis in adolescent and adult patients
- (2013) D. Garmhausen et al. ALLERGY
- Phosphodiesterase-4 inhibitors: a review of current developments (2010 – 2012)
- (2013) Amadeu Gavaldà et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference
- (2011) M. E. Schram et al. ALLERGY
- Regulation of the immune response and inflammation by histamine and histamine receptors
- (2011) Liam O’Mahony et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- PDE4 inhibitors: a review of current developments (2005 – 2009)
- (2009) Lluís Pagès et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Guidelines for management of atopic dermatitis
- (2009) Hidehisa SAEKI et al. JOURNAL OF DERMATOLOGY
- ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis
- (2009) U Darsow et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown
- (2009) Miles D. Houslay TRENDS IN BIOCHEMICAL SCIENCES
- Is eczema really on the increase worldwide?
- (2007) Hywel Williams et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now